|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Molecular markers(PECAM-1,ICAM-3,HLA-DR)determine prognosis in primary non-Hodgkin's gastric lymphoma patients显示文摘瞄准:与主要 non-Hodgkin 的胃的淋巴瘤在病人调查 PECAM-1, ICAM-3 和 HLA 医生抗原的预示的意义。方法:我们免疫组织化学地在 36 个 B 房间麦芽类型主要胃的淋巴瘤病人学习了 PECAM-1, ICAM-3 和 HLA 医生抗原表示。十非恶意并且十个健康胃的织物标本被用作控制。Clinicopathological 和幸存数据与染色的结果被相关。结果:HLA 医生抗原表示在 33 个胃的淋巴瘤病人(91.7%) 和 6 个非恶意的病人(54.5%) 被检测。PECAM-1 染色了 10 个病人(27.8%) 的肿瘤房间, 9 个病人(25%) 的 endothelial 并且煽动性有良性的胃的疾病的 4 个病人(40%) 渗入。ICAM-3 表示在 17 个病人(47.2%) 的肿瘤房间上被观察,当 5 个非恶意的病人(50%) 被染色时积极也。任何一个都没为任何学习的基因健康控制被染色。在里面多,变量分析, HLA 医生抗原和 PECAM-1 被证明是与联系的统计上重要的独立预示的因素一赞成并且不利预后分别地(P=0.009 和 P=0.003 ) 。在 univariate 分析, PECAM-1 (+)/ICAM-3 (-) 和 HLA 医生(-)/ICAM-3 (-) 病人与确切相反的基因表示模式与那些相比展出了显著地减少的全面幸存(P=0.0041 和 P=0.0091,分别地) 。是 HLA 医生(+)/ICAM-3 (+)/PECAM-1 (-)(n=8 ) 的那些病人让显著地更高的幸存与这个组(n=24 )(P=0.0289 ) 的其余部分相比评价。结论:PECAM-1, ICAM-3 和 HLA 医生分别地是肿瘤扩大潜力和主人免疫者监视的代表性的标记。他们的联合使用可以帮助我们识别能得益于更好攻击的治疗学的协议的高风险的病人。 | Alexander Darom Ilias P Gomatos Emmanuel Leandros Emmu Chatzigianni Dimitris Panousopoulos Manousos M Konstadoulakis George Androulakis | 2006 | World Journal of Gastroenterology2006，12，12： | 4 |
| 2 | Strategies for the management of hepatocellular carcinoma显示文摘 | Schwartz M Roayaie S Konstadoulakis M | | 0，，07： | 1 |
| 3 | Strategies for the management of hepatocellular carcinoma显示文摘 | Schwartz M Roayaie S Konstadoulakis M | 2007 | Nat Clin Pract Oncol2007，4，7： | 1 |
| 4 | Can expression of apoptosis genes,bcl-2 and bax,predict survival and responsiveness to chemotherapy in nodenegative breast cancer patients显示文摘 | Kymionis GD Dimitrakakis CE Konstadoulakis MM | 2001 | J Surg Res2001，99，2： | 1 |
| 5 | Malignant melanoma of the female genital system显示文摘 | KONSTADOULAKIS M M RICANIADIS N DRISCOLL D L | | 0，，02： | 1 |
| 6 | Can expression of apoptosis genes,bcl-2 and bax predict survival and responsiveness to chemotherapy in node negative breast cancer patients?显示文摘 | Kylmionis GD Dimitrakakis CE Konstadoulakis MM | 2001 | J Surg Res2001，99，2： | 1 |
| 7 | Strategies for the management of hepatocellular carcinoma显示文摘 | Schwartz M Roayaie S Konstadoulakis M | 2007 | Nat Clin Prac Oncol2007，4，： | 1 |
| 8 | Can expression of apoptosis genes, Bcl-2 and bax, pre- dict survival and responsiveness to chemotherapy in node- negative breast cancer patients? 显示文摘 | Kymionis GD Dimitrakakis CE Konstadoulakis MM | 2001 | J Surg Res2001，99，2： | 1 |
| 9 | Ag- gressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience 显示文摘 | Konstadoulakis MM Roayaie S Gomatos IP | 2008 | Am J Surg2008，196，2： | 1 |
| 10 | Postchemotherapy resection of a primary mature malignant retroperitoneal teratoma in an adult:report of a case显示文摘 | Leandros E Alexakis N Konstadoulakis M | 2005 | Surg Today2005，35，11： | 1 |
| 11 | Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Au- dit of a single center' s experience显示文摘 | Konstadoulakis MM Roayaie S Gomatos IP | 2008 | Am J Surg2008，196，2： | 1 |
| 12 | Poly -L-lysine causes false positive results in ELISA methods detecting anti-dsDNA antibodies显示文摘 | Kroubouzns G Tosca A Konstadoulakis M M | 1992 | J Immunol Methods1992，148，12： | 1 |
| 13 | Strategies for the man- agement of hepatocellular carcinoma 显示文摘 | Schwartz M Roayaie S Konstadoulakis M | 2007 | Natclin Pract Oncol2007，4，7： | 1 |
| 14 | Poly-L-lysine causes false positive results in ELISA methods detecting anti-dsDNA antibodies 显示文摘 | Kroubouzos G Tosca A Konstadoulakis M M | 1992 | J Immunol Methods1992，148，2： | 1 |
| 15 | Intraoperative findings and postoperative complications in laparoscopic cholecystectomy: the Greek experience with 5,539 patients in a single center 显示文摘 | Konstadoulakis MM Antonakis PT Karatzikos G | 2004 | J Laparoendosc Adv Surg Tech A2004，14，1： | 1 |
| 16 | Potchemotherapy resection of a primary mature malignant retroperitoneal teratoma in an adult:report of a case显示文摘 | Leandros E Alexakis N Konstadoulakis M | 2005 | Surg Today2005，35，： | 1 |
| 17 | Can expression of apoptosis genes,bcl-2 and bax,predict survival and responsiveness to chemotherapy in node negative breast cancer patients?显示文摘 | Kylmionis GD Dimitrakakis CE Konstadoulakis MM | 2001 | J Surg Res2001，99，2： | 1 |
| 18 | Aggressive surgical resec-tion for hilar cholangiocarcinoma:is it justified? Auditof a single center's experience显示文摘 | Konstadoulakis M M Roayaie S? Gomatos I P LabowD Fiel M I Miller C M | 2008 | Am J Surg2008，196，： | 1 |
| 19 | Strategies for the manage-ment of hepatocellular carcinoma显示文摘 | Schwartz M Roayaie S Konstadoulakis M | 2007 | Nat Clin Pract Oncol2007，4，： | 1 |
| 20 | Strategies for the management of hepatocellular carcinoma显示文摘 | Schwartz M Roayaie S Konstadoulakis M | 2007 | Nat Clin Pract Oncol2007，4，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员